Director WOLF DALE B buys 8.0K shares of AHCO at $8.96; holdings now 104.2K (+8.3%)
Director WOLF DALE B purchased 8,000 shares at $8.96 on 2026-02-27, increasing his holdings from 96,235 to 104,235 shares. His cross-ticker track record shows 3 prior open-market buys with avg 30d return +21.7%, avg 90d return +22.0%, and 100.00% win rate, suggesting a history of well-timed acquisitions. However, context tempers this signal: AdaptHealth's fundamentals are mixed—the company was unprofitable over its most recent full fiscal year with annual revenue growth of -0.5%, though it posted $24.5M in net income and $820.3M in revenue in the latest quarter. The stock trades at $9.40 currently, -17.4% from its 52-week high and -6.5% over the past 30 days, positioning this purchase at a relatively depressed point in the stock's recent range, though this alone does not establish conviction or timing. The magnitude of the position increase (+8.3%) is material and represents meaningful capital deployment into a name with execution headwinds.